These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18863664)

  • 1. Studies on 3,4-dimethyl-5-sulfanilamido-isoxazole (Nu-445) in humans.
    SARNOFF SJ
    Proc Soc Exp Biol Med; 1948 May; 68(1):23-6. PubMed ID: 18863664
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of pneumonia and other infections with a soluble sulfonamide, gantrosan (NU-445; 3,4-dimethyl-5-sulfanilamido-isoxazole).
    BRICKHOUSE RL; LEPPER MH
    Am J Med Sci; 1949 Aug; 218(2):133-7. PubMed ID: 18135998
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological and chemotherapeutic properties of 3,4-dimethyl-5-sulfanilamido-isoxazole.
    SCHNITZER RJ; FOSTER RH
    J Pharmacol Exp Ther; 1946 Sep; 88(1):47-57. PubMed ID: 20274525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early results of 3,4-dimethyl-5-sulfanilamido-isoxazole therapy of acute and chronic infections of the lung].
    ANNEDDA L; ROMAGNANI L
    Gazz Med Ital; 1953 May; 112(5):146-9. PubMed ID: 13083873
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative merits of 3, 4-dimethyl-5-sulfanilamido-isoxazole (gantrisin) and a sulfapyrimidine triple mixture; an evaluation of properties important at the bedside.
    LEHR D
    Antibiot Chemother (Northfield); 1953 Jan; 3(1):71-93. PubMed ID: 24542282
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative experimental studies on 5-methyl-3-sulfanilamido-isoxazole, other sulfanilamides and antibiotics].
    FUST B; BOEHNI E
    Schweiz Med Wochenschr; 1962 Dec; 92():1599-604. PubMed ID: 13945938
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with the new sulfonamide 5-methyl-3-sulfanilamido-isoxazole].
    HOCHULI E
    Schweiz Med Wochenschr; 1962 Dec; 92():1604-7. PubMed ID: 13963750
    [No Abstract]   [Full Text] [Related]  

  • 8. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
    WOERFFEL U; BEHNISCH R
    Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the kinetics, elimination & transit of gantrisin (3,4-dimethyl-5-sulfanilamido-isoazole). I].
    LAPP C
    Clin Chim Acta; 1957 Oct; 2(5):429-41. PubMed ID: 13489880
    [No Abstract]   [Full Text] [Related]  

  • 10. The experimental pharmacology and effectiveness of 3-4, dimethyl-5-sulfanilamide-isoxazole.
    BRYER MS; SCHOENBACH EB
    Bull Johns Hopkins Hosp; 1948 Jun; 82(6):633-5. PubMed ID: 18856850
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacteremia following tooth extraction; prevention with penicillin and 3,4-dimethyl-5-sulfanilamide-isoxazole.
    RHOADS PS; SCHRAM WR
    J Lab Clin Med; 1948 Nov; 33(11):1461. PubMed ID: 18890046
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicologic and metabolic studies on 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
    RANDALL LO; BAGDON RE; ENGELBERG R
    Toxicol Appl Pharmacol; 1959 Jan; 1(1):28-37. PubMed ID: 13625313
    [No Abstract]   [Full Text] [Related]  

  • 13. CHEMICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    WIEGAND RG; CHUN AH; SCHERFLING E; LOPEZ F; HERTING RL
    Antimicrob Agents Chemother (Bethesda); 1964; 10():549-53. PubMed ID: 14287991
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapeutic activity of 6-sulfanilamido-2,4-dimethylpyrimidine (elkosin).
    EISMAN PC; GEFTIC SG; LIGENZOWSKI F; MAYER RL
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):493-5. PubMed ID: 14949095
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE PHARMACOKINETICS OF A LONG-ACTING SULFONAMIDE (4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE) IN NORMAL PERSONS].
    PORTWICH F; BUETTNER H
    Klin Wochenschr; 1964 Aug; 42():740-4. PubMed ID: 14296354
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapeutic studies with 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
    SCHNITZER RJ; DELORENZO WF; GRUNBERG E; RUSSOMANNO R
    Proc Soc Exp Biol Med; 1958 Nov; 99(2):421-4. PubMed ID: 13601890
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of 4-sulfanilamido-6-methoxypyrimidine in standardized infections in mice.
    REDIN GS; McCOY ME
    Chemotherapia (Basel); 1962; 4():386-97. PubMed ID: 14490938
    [No Abstract]   [Full Text] [Related]  

  • 18. SERUM CONCENTRATION AND ANTIBACTERIAL ACTIVITY OF 4-SULFANILAMIDO-5,6DIMETHOXYPYRIMIDINE.
    MADSEN ST
    Am J Med Sci; 1964 Feb; 247():217-22. PubMed ID: 14124711
    [No Abstract]   [Full Text] [Related]  

  • 19. The bacteriologicoclinical evaluation of 2,4-dimethoxy-6-sulfanilamido-1, 3-diazine (Madribon) in various urological disorders associated with urinary tract infection.
    SIERP M; DRAPER JW
    Ann N Y Acad Sci; 1959 Sep; 82():92-104. PubMed ID: 14446539
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical evaluation of a recent sulfonamide, Nu-445.
    RODGERS RS; COLBY FH
    J Urol; 1948 Apr; 59(4):659-63. PubMed ID: 18906152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.